CMOPF (Cosmo NV) Inventory Turnover: 2.48 (As of Dec. 2025)

What is Cosmo NV Inventory Turnover?

Cosmo NV CMOPF +0.67% 79 Inventory Turnover is 2.48 as of Dec. 2025. GuruFocus rates CMOPF with a GF Score™ of 79/100 and a GF Value™ of $54.27 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Cosmo NV's Cost of Goods Sold for the six months ended in Dec. 2025 was $32.8 Mil. Cosmo NV's Average Total Inventories for the quarter that ended in Dec. 2025 was $13.2 Mil. Cosmo NV's Inventory Turnover for the quarter that ended in Dec. 2025 was 2.48.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cosmo NV's Days Inventory for the six months ended in Dec. 2025 was 73.60.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cosmo NV's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.22.

Cosmo NV (OTCPK:CMOPF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cosmo NV's Days Inventory for the six months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	13.244	/	32.842	*	365 / 2
	=	73.60

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cosmo NV's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	13.244	/	61.422
	=	0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Cosmo NV Inventory Turnover Related Terms

Cosmo NV Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Cosmo NV's Inventory Turnover can be seen below:

Cosmo NV Inventory Turnover Chart

Cosmo NV Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

1.57

1.47

1.51

3.21

4.76

Cosmo NV Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Inventory Turnover	Get a 7-Day Free Trial															0.02	1.64	1.60	2.08	2.48

79GF Score

Cosmo NV CMOPF

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cosmo NV Inventory Turnover Calculation

Cosmo NV's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	62.785	/ (	(14.147	+	12.21)	/	2 )
=	62.785	/	13.1785
=	4.76

Cosmo NV's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

	Inventory Turnover (Q: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Dec. 2025 )	/ (	(Total Inventories (Q: Jun. 2025 )	+	Total Inventories (Q: Dec. 2025 ))	/	count )
=	32.842	/ (	(14.278	+	12.21)	/	2 )
=	32.842	/	13.244
=	2.48

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 2.48 mean?

Cosmo NV (CMOPF) has a Inventory Turnover of 2.48 as of Dec. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Cosmo NV and its competitors.

Is Cosmo NV's Inventory Turnover too high?

Cosmo NV's current Inventory Turnover is 2.48. Overall, Cosmo NV has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Cosmo NV's Inventory Turnover compare to LLY and JNJ?

Cosmo NV's Inventory Turnover of 2.48 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Cosmo NV and its competitors. Cosmo NV's current Inventory Turnover is 2.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cosmo NV stock overvalued right now?

Based on GuruFocus' analysis, Cosmo NV (CMOPF) is currently considered Significantly Overvalued. The stock's GF Value™ is $54.27, compared to a current price of $82.60 — trading 52.2% above its estimated fair value. The current Inventory Turnover is 2.48. Cosmo NV's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Cosmo NV (CMOPF), the current Inventory Turnover is 2.48 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmo NV (CMOPF) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo NV stock appears to be overvalued. The current stock price of $82.60 is trading 52.2% above its estimated GF Value™ of $54.27. GuruFocus considers Cosmo NV to be Significantly Overvalued.

Key valuation signals for CMOPF:

Inventory Turnover: 2.48
GF Value™: $54.27 vs. price of $82.60 (52.2% above fair value)
GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the CMOPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmo NV Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XSWX:PPGN XSWX:CURN XSWX:SFZN LLY JNJ ABBV XSWX:ROP MRK XSWX:NOVN LSE:AZN OCSE:NOVO B AMGN GILD PFE BMY LSE:GSK XPAR:SAN TSE:4519 XTER:BAYN TSE:4578

Other Exchanges COPNz:UK 0RGI:UK C43:Germany COPN:Switzerland COPN:Austria

Address 91/94 North Wall Quay, 7th Floor, One North Dock, Dublin, IRL, D01 H7V7

Website https://www.cosmopharma.com

Cosmo NV is is a life sciences company. The company is focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). The company designs, develops, and manufactures solutions to address critical medical needs. Its technologies are trusted by international pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. The product pipeline includes Eleview, GI Genius, Winlevi, Lialda, Uceris, and others.

79GF Score

Get the complete analysis for CMOPF

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$82.60

Price

$54.27

GF Value

View CMOPF Analysis

See Inventory Turnover data for all stocks →